CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Table 1 Study populations

Population characteristics	Controls	NAFLD	NASH
Number	16	15	17
Male/female	8/8	12/3	16/1
Mean age (range)	37 yr (26-69 yr)	48 yr (26-75 yr)	45 yr (20-74 yr)
AST (mean ± SD)	20.6 ± 4.5	19.3 ± 5b	45.2 ± 22.1d
ALT (mean ± SD)	24.4 ± 7.0	27.4 ± 8.1b	86.4 ± 55.7d
GGT (mean ± SD)	18.3 ± 10.1	25.6 ± 20b	73.1 ± 43d
ALP (mean ± SD)	144.4 ± 45.4	154.1 ± 38.3	176.5 ± 57.4

^bP < 0.001, NAFLD vs NASH;

^dP < 0.001, NASH vs controls. AST: Aspartate aminotransferase: reference range 0-37 (IU/L); ALT: Alanine aminotransferase: reference range 0-40 (IU/L); GGT: Gamma-glutamyl transferase: reference range 7-50 (IU/L); ALP: Alkaline phosphatase: reference range 98-279 (IU/L); NASH: Non-alcoholic steatohepatitis; NAFLD: Non-alcoholic fatty liver disease.